Edition:
United Kingdom

Siegfried Holding AG (SFZN.S)

SFZN.S on Swiss Exchange

309.75CHF
12 Dec 2017
Change (% chg)

CHF3.50 (+1.14%)
Prev Close
CHF306.25
Open
CHF307.25
Day's High
CHF310.00
Day's Low
CHF305.25
Volume
10,434
Avg. Vol
11,867
52-wk High
CHF327.00
52-wk Low
CHF203.10

Summary

Name Age Since Current Position

Andreas Casutt

54 2014 Non-Executive Chairman of the Board of Directors

Rudolf Hanko

62 2009 Chief Executive Officer, Member of the Executive Committee

Reto Suter

46 2017 Chief Financial Officer, Member of the Executive Committee

Rene Imwinkelried

60 2016 Head of Technical Operations, Head of Research & Development, Member of the Executive Committee

Wolfgang Wienand

45 2017 Chief Scientific and Strategy Officer, Member of the Executive Committee

Marianne Spaene

55 2010 Head of Business Development, Marketing & Sales, Member of the Executive Committee

Arnoud Middel

46 2011 Head of Human Resources, Member of the Executive Committee

Colin Bond

56 2013 Non-Executive Member of the Board of Directors

Wolfram Carius

56 2014 Non-Executive Member of the Board of Directors

Reto Garzetti

57 2011 Non-Executive Member of the Board of Directors

Martin Schmid

48 2016 Non-Executive Member of the Board of Directors

Ulla Schmidt

68 2016 Non-Executive Member of the Board of Directors

Biographies

Name Description

Andreas Casutt

Dr. Andreas Casutt, Ph.D., has been Non-Executive Chairman of the Board of Directors of Siegfried Holding Ltd since 2014. Prior to that, he was Non-Executive Vice Chairman of the Board of Directors at the Company from April 20, 2012. He has served as Non-Executive Member of the Board of Directors of Siegfried Holding AG since April 14, 2010. He has been Partner of the Niederer Kraft & Frey law firm in Zurich since 2002, and held office as managing partner from 2006 to 2014. He specializes in corporate law, contract law, mergers & acquisitions, and stock exchange law. In addition, he is Board Member of Mikron Holding AG, Maxon Motor AG, Liechtenstein-based Bendura Bank AG and various privately held companies. He studied law and received his Ph.D. in Zurich (Switzerland) and completed an LL.M. program at the University of Michigan, Ann Arbor.

Rudolf Hanko

Dr. Rudolf Hanko, Ph.D., has been Chief Executive Officer and Member of the Executive Committee of Siegfried Holding Ltd since May 1, 2009. Prior to joining Siegfried, he worked in the chemical-pharmaceutical industry in various management positions, at Evonik Industries AG (Germany) as head of Exclusive Synthesis & Amino Acids. Dr. Hanko also headed the pharmaceutical division of Bayer AG as head of Chemical Research and as General Manager of the fine chemicals division. He received his Ph. D. in Chemistry from Georg-August-Universitaet Goettingen and completed post-doctoral studies at the Max Planck Institute (Germany).

Reto Suter

Dr. Reto Suter, Ph.D., has been Chief Financial Officer and Member of the Executive Committee at Siegfried Holding Ltd since May 1, 2017. Over the last 16 years, he has held a range of responsible positions in industry as well as in finance and private equity. In his last post as Chief Operation Officer, Chief Information Officer and Board Member, he was responsible for overseeing the public takeover and subsequent delisting and restructuring of Lonrho, a long-established company headquartered in London and Johannesburg. He studied economics at the University of Zurich and the University of Washington in Seattle and took his doctorate in banking and finance at the University of Zurich.

Rene Imwinkelried

Dr. Rene Imwinkelried, Ph.D., has been Head of Technical Operations, Head of Research & Development and Member of the Executive Committee at Siegfried Holding Ltd since November 1, 2016. He has been Member of the Executive Committee, Head Research & Development at the Company since September 2012. He holds a Ph.D. in organic chemistry from the ETH Zurich and completed a post-doctoral fellowship at Colorado State University and Howard University. From 1991 to 2004, he worked in various R&D management positions at Lonza, and as Head of global chemical and physical sciences at Schering-Plough. From 2010 to 2012, he was Head of Technical Development Small Molecules at Roche in Basel.

Wolfgang Wienand

Dr. Wolfgang Wienand, Ph.D., has been Chief Scientific and Strategy Officer, Member of the Executive Committee at Siegfried Holding Ltd since May 1, 2017. He leads Siegfried’s global Research & Development activities. In addition to this role he continues to be responsible for Strategy, Mergers & Acquisitions, Legal, Intellectual Property and Regulatory Affairs Management. He joined Siegfried in 2010 as Chief Scientific Officer and Head of Research & Development (until August 2012) before becoming Chief Strategy Officer and Head of Strategy and Mergers & Acquisitions in December 2011. Before joining Siegfried, he held senior management positions at Evonik Industries AG, formerly Degussa AG, mainly in the fields of fine chemicals and custom manufacturing for the pharmaceutical industry. At last he was responsible for strategy, business development and key account management of Evonik’s Advanced Silanes business with the photovoltaic and semiconductor industries. He studied chemistry at the Friedrich-Wilhelms University in Bonn and received his Ph.D. in organic and bioorganic chemistry from the University of Cologne, both in Germany. He also holds an executive master’s degree in international finance from HEC Ecole des Hautes Etudes Commerciales de Paris, France.

Marianne Spaene

Ms. Marianne Spaene has been Head of Business Development, Marketing & Sales and Member of the Executive Committee at Siegfried Holding Ltd since March 1, 2010. She joined the Siegfried Group in 2004 and was appointed Head of Business Development & Sales in March 2010. She headed the Siegfried Generics Division from 2008 to 2010 and was previously responsible for the Classical Generics Business Unit. From 2004 to 2008, Ms. Spane managed the Business Development Department and the Supply Chain for Generics. Prior to joining Siegfried, she worked in logistics, business development and as site manager for Boucheron, a cosmetics company. Later, Ms. Spane moved to the pharmaceutical industry and joined the pharma division of Schweizerhalle as Head of the Sales and Marketing department. Subsequently, she joined Aceto, where she developed European expansion strategies. Ms. Spane holds degrees in finance, business administration and marketing from the Business Management School (KFS) in Basel and the Marketing & Business School in Zurich (MBSZ).

Arnoud Middel

Mr. Arnoud Michael Middel has been Head of Human Resources and Member of the Executive Committee at Siegfried Holding Ltd since September 1, 2011. Previously, he worked for various companies in the field of human resources. From 2003 to 2006, he held a position in the Human Resources department of the Baloise insurance Switzerland. From 2006 to 2008, he was Head of Human Resources for the region Continental Europe and Asia of the American industry- and reinsurance group XL-Insurance. From 2008 to 2011, he worked as Head of Human Resources Switzerland and Global Headquarters for Syngenta in Basel (Switzerland). He completed his studies in biology and biochemistry at the University of Basel (Switzerland).

Colin Bond

Mr. Colin Bond has been Non-Executive Member of the Board of Directors of Siegfried Holding Ltd since May 2013. He is Chairman of the Audit Committee at the Company. In 2016, he has been appointed Chief Financial Officer of Vifor Pharma AG, a company of the Galenica group. Previously, Mr. Bond held the position of Group Chief Financial Officer of Evotec in Hamburg. Following career stations as a pharmacist, chartered accountant and management consultant, he worked for 25 years as Chief Financial Officer for several international companies in various industries, of which 11 years for Great Lakes Chemical Corporation, today Chemtura, a global specialty chemicals company. Mr. Bond holds a university degree in pharmacy from the University of Aston, Birmingham, and a MBA degree from London Business School.

Wolfram Carius

Prof. Dr. Wolfram Carius, Ph.D., has been Non-Executive Member of the Board of Directors of Siegfried Holding Ltd since 2014. He is Chairman of the Strategy Committee at the Company. In 2016, he was appointed Executive Vice President Pharmaceutical Product Supply by Bayer and, in this function, he serves as Member of the Executive Leadership Team. Previously, he worked for Sanofi, a French healthcare company, as Senior Vice President Biopharma Biologics and Member of the Global Leadership Team. From 1987 to 2013, he held various positions with Boehringer Ingelheim. In 2009, he was appointed to the company’s Board of Managing Directors, initially with responsibility for Human Resources and Technical Operations, and from 2012 for Biopharma and Operations. Before that, he was responsible for the development and expansion of the biopharma unit. He managed the company’s production site in Japan and worked later in Brazil as technical director before being appointed member of Boehringer Ingelheim’s Board of Managing Directors in Germany. He holds a Ph.D. in pharmaceutical biology and analytical phytochemistry from the University of Saarland, Germany. In 2009, the Biberach University of Applied Sciences awarded him the title of honorary professor in recognition of his long and exceptional service.

Reto Garzetti

Mr. Reto A. Garzetti has been Non-Executive Member of the Board of Directors at Siegfried Holding Ltd since May 24, 2011. He is also Member of Company’s Audit Committee, Strategy Committee and the Remuneration Committee. He is Partner and Vice President of the Board of SE Swiss Equities. He additionally serves on the Board of SKW Stahl Metallurgie Holding AG (until 2016), listed on the German stock exchange, the Board of Peach Properties AG (president), listed on the SIX Swiss Exchange, as well as on the Board of the privately held companies AGI AG, HFS Helvetic Financial Services AG, Occlutech AG and other privately held companies in Switzerland and abroad. Previously, he served for many years on the Board of multinational US companies. Mr. Garzetti graduated from the University of Zurich in business administration (lic. oec. publ. / MBA) with the main emphasis on banking, trade and securities law.

Martin Schmid

Dr. Martin Schmid, Ph.D., has been Non-Executive Member of the Board of Directors at Siegfried Holding Ltd since 2016. He is Member of the Remuneration Committee at he Company. He was elected Councilor of State for the Canton of Grisons in 2011. From 2003 to 2011, he served as Member of the Canton of Grisons government, where he was in charge of the Department of Justice, Security, and Health as well as subsequently the Department of Finance. He is an attorney at law and serves on several boards in the fields of energy and construction. He is President of the Swiss gas industry association (VSG ASIG), of the foundation of the Cantonal Hospital Grisons and of the Institute for financial economy and financial law (IFF) of the University of St. Gallen. Furthermore, he is Board Member of economiesuisse, a Swiss corporate union. He studied law at the University of St. Gallen where he was awarded a Ph.D. in 2005.

Ulla Schmidt

Ms. Ulla Schmidt has been Non-Executive Member of the Board of Directors at Siegfried Holding Ltd since 2016. She is Member of the Strategy Committee at the Company. She has been Member of the German Bundestag since 1990 and its Vice President since 2013. From 2001 to 2009, she held the position of Federal Minister of Health in the Republic of Germany. She served in several public office functions; among others as City Councilor in Aachen. Ms. Schmidt is Chairwoman of the Board of Federal Lebenshilfe Association headquartered in Marburg, Germany, an Expert Member on the Supervisory Board of Charite – University Medicine Berlin, and Member of the Advisory Committee of K&S Sozialbau AG, Sottrum. Furthermore, she serves on the Board of Aktion Mensch, Bonn, and is Chairwoman of the Board of Trustees of Hospizstiftung Region Aachen and Member of the Board of Philips GmbH. Ms. Schmidt holds a prediploma in psychology and was awarded a school teaching degree from the University of Aachen.

Basic Compensation